Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis

NCT07130604 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: D-2570
DRUG: Placebo

Sponsor

InventisBio Co., Ltd